These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 18927524)

  • 41. Effect of different antihypertensive treatments on Ras, MAPK and Akt activation in hypertension and diabetes.
    Fernández-Campo L; Grande MT; Diego J; Fuentes-Calvo I; Macías-Núñez JF; Sánchez-Rodríguez A; Grande J; García-Ortiz L; López-Novoa JM; Martínez-Salgado C
    Clin Sci (Lond); 2009 Jan; 116(2):165-73. PubMed ID: 18588512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Risk factors to be considered at the beginning of antihypertensive therapy in diabetes mellitus].
    Jermendy G
    Orv Hetil; 2004 May; 145(18):949-56. PubMed ID: 15188641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hypertension, insulin resistance and diabetes mellitus: pathophysiological interactions and therapeutic consequences].
    Schernthaner G
    Wien Klin Wochenschr; 1990 Dec; 102(24):707-12. PubMed ID: 1980767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Choice of antihypertensive drug in the diabetic patient.
    Ong HT; Cheah JS
    MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood pressure, antihypertensive treatment and factors associated with good blood pressure control in hypertensive diabetics: the Tarmidas study.
    de Pablos-Velasco P; Gonzalez-Albarran O; Estopiñan V; Khanbhai A
    J Hum Hypertens; 2007 Aug; 21(8):664-72. PubMed ID: 17460709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S; Nath V; Coyne DW
    Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension.
    White WB
    Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The angiotensin II inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy].
    Shamkhlova MSh; Trubitsyna NP; Katsaia GV; Goncharov NP; Malysheva NM; Il'in AV; Nikankina LV; Koshel' LV; Shestakova MV
    Ter Arkh; 2008; 80(1):49-52. PubMed ID: 18326228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 12-month comparison of ACE inhibitor and CA antagonist therapy in mild to moderate essential hypertension--The GLANT Study. Study Group on Long-term Antihypertensive Therapy.
    Hypertens Res; 1995 Sep; 18(3):235-44. PubMed ID: 7584934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study.
    Martinez-Martin FJ; Saiz-Satjes M
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1347-55. PubMed ID: 19018688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hypertension combination therapy with renin-angiotensin system blockers].
    Soucek M
    Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antihypertensive therapy in 357 inpatients of elderly isolated systolic hypertension].
    Zhai LH; Yang CY; Jiang KW; Xu XY; Lu HZ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):719-22, 725. PubMed ID: 16708819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term persistence with antihypertensive drugs in new patients.
    Degli Esposti E; Sturani A; Di Martino M; Falasca P; Novi MV; Baio G; Buda S; Volpe M
    J Hum Hypertens; 2002 Jun; 16(6):439-44. PubMed ID: 12037702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
    Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
    Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythropoietin resistance in patients on continuous ambulatory peritoneal dialysis.
    Nakamoto H; Kanno Y; Okada H; Suzuki H
    Adv Perit Dial; 2004; 20():111-6. PubMed ID: 15384808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacotherapeutical features of arterial hypertension in patients with diabetes mellitus].
    Okunevich IV; Khnychenko LK; Sapronov NS
    Klin Med (Mosk); 2007; 85(1):52-7. PubMed ID: 17419357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antihypertensive drug utilization in obese patients].
    Bramlage P; Bramlage C; Kirch W
    Med Klin (Munich); 2005 Dec; 100(12):804-9. PubMed ID: 16453095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.